| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |